Oncology & Cancer
Breast cancer types and what your type means
October is Breast Cancer Awareness Month, which makes this a good time to learn about breast cancer types and what your type means.
Oct 5, 2022
0
29
Carcinoma
Radiology & Imaging
Novel imaging system could mean near-instant biopsy results
Medicine has advanced dramatically during the last century. But when it comes to getting biopsy results, very little has changed. Consider, for example, what happens when a patient comes in to have a skin lesion biopsied ...
Sep 27, 2022
0
73
Medications
Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma
Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrectomy relapse, according ...
Sep 14, 2022
0
9
Medical research
Review sheds light on protein drug target for treating non-alcoholic fatty liver disease
It is a known fact that consuming a large amount of alcohol, even for a few days, triggers fat accumulation in the liver and ultimately leads to alcohol-related liver diseases. When fat accumulation occurs in the liver even ...
Sep 13, 2022
0
7
Medical research
Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients
Merkel cell carcinoma is a rare but aggressive form of skin cancer that has a high rate of metastasis and poor patient outcomes. The current standard of care for patients with recurrent, unresectable or metastatic disease ...
Sep 12, 2022
0
9
Medical research
A new therapeutic target against the most common lung cancer
TIMP-1 protein levels in both tissues and blood have been repeatedly associated with a poor prognosis in lung cancers, but its role has been unknown. Now, a study led by Jordi Alcaraz, lecturer at the Faculty of Medicine ...
Sep 12, 2022
0
24
Oncology & Cancer
First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of neoadjuvant immunotherapy in patients with kidney cancer. Patients with high-risk renal ...
Sep 8, 2022
0
16
Oncology & Cancer
New imaging technique improves accuracy of diagnosis for most common skin cancer
A novel imaging technique significantly improves the accuracy of the diagnosis of basal cell carcinoma (BCC)—the most frequent skin cancer—compared to clinical and dermoscopic examinations alone, according to new research ...
Sep 7, 2022
0
4
Immunology
Immune therapies against chronic hepatitis B
Hepatitis B virus (HBV) infection is global in nature and induces several liver diseases, such as chronic hepatitis B (CHB), cirrhosis of the liver (LC) and hepatocellular carcinoma (HCC). A total of 882,000 patients died ...
Sep 5, 2022
0
15
Oncology & Cancer
Global disease burden related to nonmelanoma skin cancer explored
The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 in BMC Cancer.
Sep 1, 2022
0
7
